Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Other Non Operating Income: 2012-2025

Historic Other Non Operating Income for Aytu Biopharma (AYTU) over the last 12 years, with Jun 2025 value amounting to -$1.7 million.

  • Aytu Biopharma's Other Non Operating Income rose 31.39% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$799,000, marking a year-over-year decrease of 116.70%. This contributed to the annual value of -$1.7 million for FY2025, which is 57.47% up from last year.
  • Aytu Biopharma's Other Non Operating Income amounted to -$1.7 million in FY2025, which was up 57.47% from -$4.0 million recorded in FY2024.
  • Aytu Biopharma's 5-year Other Non Operating Income high stood at $4.8 million for FY2023, and its period low was -$4.0 million during FY2024.
  • Its 3-year average for Other Non Operating Income is -$304,667, with a median of -$1.7 million in 2025.
  • Per our database at Business Quant, Aytu Biopharma's Other Non Operating Income soared by 198.63% in 2023 and then tumbled by 183.54% in 2024.
  • Over the past 5 years, Aytu Biopharma's Other Non Operating Income (Yearly) stood at -$2.0 million in 2021, then soared by 178.29% to $1.6 million in 2022, then surged by 198.63% to $4.8 million in 2023, then tumbled by 183.54% to -$4.0 million in 2024, then surged by 57.47% to -$1.7 million in 2025.